June 2007




Addressing Unanswered Questions

By Takao Ohki, MD, PhD, Chief Medical Editor


Percutaneous Renal Revascularization and Medicare Coverage

The Society of Interventional Radiology's position on the current CMS coverage of renal interventions.

By David Sacks, MD, and Timothy P. Murphy, MD


A Combination Approach to Mesenteric Venous Thrombosis

Using percutaneous transhepatic thrombectomy and pharmacological thrombolysis to treat this highly morbid condition.

By Wei Zhou, MD; Tam T. Huynh, MD; and Peter H. Lin, MD


Excimer Laser as an Adjunct for Popliteal Aneurysms

A case report demonstrating the use of this novel technique.

By Mark W. Moritz, MD, FACS, and Michael Ombrellino, MD, FACS


What Is the Correct Endpoint?

Discerning endpoints for clinical trials in endovascular therapy for infrainguinal arterial disease.

By Michael R. Jaff, DO

TASC II 2007: What Has Changed?

An interview with TASC II Co-Chair Lars Norgren, MD, PhD, FRCS, regarding the recently updated and published recommendations.

By TASC II Co-Chair Lars Norgren, MD, PhD, FRCS

Setting the Stage for Future Lower-Extremity Device Trials

Krishna Rocha-Singh, MD, of VIVA Physicians, Inc., discusses their effort to determine nitinol stenting performance goals, collaboration with the FDA and industry, and how clinicians can apply these standards to their practices.

By Krishna Rocha-Singh, MD

Why Are There So Few Vascular Stents Approved?

An interview with Jennifer Goode of the FDA.

By Jennifer Goode

Embolic Protection Questions Answered

What is the embolic risk for endovascular SFA intervention? When is embolic protection necessary?

By Michael Wholey, MD, MBA; William C.L. Wu, MD; Boulos Toursarkissian, MD; Raj Suri, MD; Marco Cura, MD; and Martin G. Radvany, MD

Drug-Eluting Stents in the Periphery

A summary of the barriers, unanswered questions, and potential benefits of this technology.

By H. Bob Smouse, MD

An Interview with Ted E. Feldman, MD

A leader in structural heart repair discusses cardiologists' increased role in the periphery, his multidisciplinary practice, and the EVEREST trial.

By Ted E. Feldman, MD

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.